Whilst this therapeutic approach is worthy of consideration for geriatric COVID-19 patients, it should be noted that in vitro studies with monocytes from older adults have demonstrated reduced up-regulation of IFN-stimulated genes following influenza A virus challenge (47). The gene discussed is IFNA1; the disease is COVID-19.